← Leaderboards
Thomas F Serwold
Stanford University
$5,079,780
Attributed
$7,668,945
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,668,945 · 7
By mechanism
R01$4,400,547 · 2
P30$2,021,832 · 2
R56$777,783 · 1
S10$363,243 · 1
F32$105,540 · 1
Top collaborators
- Michael S Kuhns5 shared
- Amy Jo Wagers2 shared
Most similar at Stanford University
Same institution · by research overlap
- John B Zuchero$3,816,100
- Ben A Barres$22,556,611
- Lei Stanley Qi$14,888,989
- John M. Pauly$18,804,688
- Charles Garrison Fathman$27,441,596
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsResponseDiabetes MellitusTechnologyBeta CellAreaNew TechnologyTissuesMuscle CellsNovel StrategiesInstrumentResearch PersonnelFlow CytometryAdipocytesComplexFluorescence-Activated Cell SortingRapid TechniqueAutoimmunityCellular DevelopmentMissionMediator Of Activation ProteinCell SeparationTechnology DevelopmentUpdate
Grant awards (20)
Engineering 2nd generation 5MCARs to monitor and treat Type-I Diabetes$824,415
R01 · FY2025 · DK
Modulating the adaptive immune response to enhance the efficiency of in vivo gene editing in muscle$537,378
R01 · FY2025 · NS · contact PI
Engineering 2nd generation 5MCARs to monitor and treat Type-I Diabetes$828,648
R01 · FY2024 · DK
Modulating the adaptive immune response to enhance the efficiency of in vivo gene editing in muscle$537,378
R01 · FY2024 · NS · contact PI
Engineering 2nd generation 5MCARs to monitor and treat Type-I Diabetes$831,071
R01 · FY2023 · DK
Engineering 2nd generation 5MCARs to monitor and treat Type-I Diabetes$841,657
R01 · FY2022 · DK
Flow Cytometry Core$208,108
P30 · FY2021 · DK · contact PI
Inducing Tolerance with 5-Module chimeric Antigen Receptor (5MCAR) T Cells$777,783
R56 · FY2020 · AI
Flow Cytometry Core$211,792
P30 · FY2020 · DK · contact PI
Flow Cytometry Core$215,051
P30 · FY2019 · DK · contact PI
Flow Cytometry Core$217,542
P30 · FY2018 · DK · contact PI
Flow Cytometry Core$219,252
P30 · FY2017 · DK · contact PI
Special BD LSRFortessa$363,243
S10 · FY2016 · OD · contact PI
Core C: Flow Cytometry Core$192,893
P30 · FY2016 · DK · contact PI
Core C: Flow Cytometry Core$182,823
P30 · FY2015 · DK · contact PI
Core C: Flow Cytometry Core$192,893
P30 · FY2014 · DK · contact PI
Core C: Flow Cytometry Core$181,805
P30 · FY2013 · DK · contact PI
Core C: Flow Cytometry Core$199,673
P30 · FY2012 · DK · contact PI
Factors that modulate thymic output$53,992
F32 · FY2006 · AI · contact PI
Factors that modulate thymic output$51,548
F32 · FY2005 · AI